SEC Form 4 · STOCK Act

Insider buys that paid off for the people who copied them.

$ZSTK

ZeroStack Corp.

+206.0%

Michael Heinrich, Executive Chair, bought $3.5M. Filed Jul 20, 6:31 PM ET.

COPIED JUL 21

$1,000 copied at the first price after the filing (Jul 21 open, $1.66) was $3,060 30 trading days later.

Example. Of 339 buys of $100K or more filed Jun 29 to Sep 11, the median lost 5.3% and 67.8% lost money over the same 30 trading days. Not investment advice.

Officers and directors must report their own stock purchases within two business days. We list every one, largest first, with what copying it would have returned.

A free account keeps a watchlist. No password: we email you a link.

BCRXSell

Biocryst Pharmaceuticals Inc

Amy E Mckee · Director

$100K−26.0%May 19
BCRXSell

Biocryst Pharmaceuticals Inc

Alane P Barnes · General Counsel

$596K−13.0%May 15
BCRXSell

Biocryst Pharmaceuticals Inc

Theresa Heggie · Director

$505K−43.0%Mar 24
BCRXSell

Biocryst Pharmaceuticals Inc

Alane P Barnes · General Counsel

$1.4M−27.0%Mar 18
BCRXSell

Biocryst Pharmaceuticals Inc

Alane P Barnes · General Counsel

$167K−5.0%Dec 23
BCRXSell

Biocryst Pharmaceuticals Inc

Alane P Barnes · General Counsel

$162K−6.0%Dec 16
BCRXSell

Biocryst Pharmaceuticals Inc

Alane P Barnes · General Counsel

$1.2M−32.0%Dec 3
BCRXSell

Biocryst Pharmaceuticals Inc

Amy E Mckee · Director

$54K−24.0%Jun 25
BCRXSell

Biocryst Pharmaceuticals Inc

Machelle Sanders · Director

$28K−14.0%Jun 17
BCRXSell

Biocryst Pharmaceuticals Inc

Theresa Heggie · Director

$41K−11.0%Jun 14
BCRXBuy

Biocryst Pharmaceuticals Inc

Alan G Levin · Director

$50K+21.0%May 31
BCRXBuy

Biocryst Pharmaceuticals Inc

Nancy J Hutson · Director

$32K+6.0%May 22
BCRXBuy

Biocryst Pharmaceuticals Inc

Vincent Milano · Director

$94K+29.0%May 22
BCRXBuy

Biocryst Pharmaceuticals Inc

Anthony Doyle · CFO

$202K+16.0%May 15
BCRXBuy

Biocryst Pharmaceuticals Inc

Helen M. Thackray · Chief R, D Officer

$176K+12.0%May 15
BCRXBuy

Biocryst Pharmaceuticals Inc

Steven K Galson · Director

$120K+74.0%May 15
BCRXBuy

Biocryst Pharmaceuticals Inc

Alane P Barnes · General Counsel

$28K+2.0%May 15
BCRXBuy

Biocryst Pharmaceuticals Inc

Jon P Stonehouse · President and CEO

$167K+3.0%May 15
BCRXBuy

Biocryst Pharmaceuticals Inc

Charles K Gayer · Chief Commercial Officer

$164K+11.0%May 15
BCRXSell

Biocryst Pharmaceuticals Inc

Machelle Sanders · Director

$32K−14.0%Jun 15
BCRXSell

Biocryst Pharmaceuticals Inc

Nancy J Hutson · Director

$103K−14.0%Jun 15
BCRXSell

Biocryst Pharmaceuticals Inc

Helen M. Thackray · Chief R, D Officer

$58K−3.0%Apr 5
BCRXSell

Biocryst Pharmaceuticals Inc

Jon P Stonehouse · President and CEO

$1.0M−9.0%Feb 2
BCRXSell

Biocryst Pharmaceuticals Inc

Jon P Stonehouse · President and CEO

$154K−2.0%Dec 19
BCRXSell

Biocryst Pharmaceuticals Inc

Helen M. Thackray · Chief R, D Officer

$34K−2.0%Dec 19
BCRXSell

Biocryst Pharmaceuticals Inc

Anthony Doyle · CFO

$62K−3.0%Dec 19
BCRXSell

Biocryst Pharmaceuticals Inc

Charles K Gayer · Chief Commercial Officer

$66K−3.0%Dec 19
BCRXSell

Biocryst Pharmaceuticals Inc

Alane P Barnes · General Counsel

$45K−2.0%Dec 19
BCRXSell

Biocryst Pharmaceuticals Inc

Michael L Jones · Exec. Dir, Finance - PAO

$112K−43.0%Dec 2
BCRXSell

Biocryst Pharmaceuticals Inc

Jon P Stonehouse · President and CEO

$3.9M−25.0%Dec 2
BCRXSell

Biocryst Pharmaceuticals Inc

Yarlagadda S Babu · Chief Discovery Officer

$437K−10.0%Nov 16
BCRXSell

Biocryst Pharmaceuticals Inc

George B Abercrombie · Director

$55K−100.0%Apr 20
BCRXSell

Biocryst Pharmaceuticals Inc

Helen M. Thackray · Chief R, D Officer

$123K−5.0%Apr 4
BCRXSell

Biocryst Pharmaceuticals Inc

William P Sheridan · Chief Medical Officer

$2.7M−81.0%Mar 14
BCRXSell

Biocryst Pharmaceuticals Inc

Yarlagadda S Babu · Chief Discovery Officer

$343K−8.0%Mar 9
BCRXSell

Biocryst Pharmaceuticals Inc

Michael L Jones · Exec. Dir, Finance - PAO

$40K−17.0%Mar 3
BCRXSell

Biocryst Pharmaceuticals Inc

George B Abercrombie · Director

$93K−100.0%Feb 16
BCRXSell

Biocryst Pharmaceuticals Inc

Jon P Stonehouse · President and CEO

$2.8M−17.0%Jan 13
BCRXBuy

Biocryst Pharmaceuticals Inc

Vincent Milano · Director

$91K+75.0%Nov 24
BCRXBuy

Biocryst Pharmaceuticals Inc

Anthony Doyle · CFO

$440K+60.0%Nov 24
BCRXSell

Biocryst Pharmaceuticals Inc

George B Abercrombie · Director

$61K−100.0%Nov 17
BCRXSell

Biocryst Pharmaceuticals Inc

Nancy J Hutson · Director

$1.6M−62.0%Oct 19
BCRXSell

Biocryst Pharmaceuticals Inc

George B Abercrombie · Director

$75K−100.0%Sep 17
BCRXSell

Biocryst Pharmaceuticals Inc

Kenneth B Lee Jr · Director

$92K−20.0%Sep 15
BCRXSell

Biocryst Pharmaceuticals Inc

George B Abercrombie · Director

$1.1M−100.0%Sep 14
BCRXSell

Biocryst Pharmaceuticals Inc

George B Abercrombie · Director

$78K−63.0%Jul 19
BCRXSell

Biocryst Pharmaceuticals Inc

Nancy J Hutson · Director

$393K−26.0%Jun 14
BCRXSell

Biocryst Pharmaceuticals Inc

William P Sheridan · Chief Medical Officer

$2.5M−92.0%Jun 1
BCRXSell

Biocryst Pharmaceuticals Inc

George B Abercrombie · Director

$93K−69.0%May 26
BCRXSell

Biocryst Pharmaceuticals Inc

Alane P Barnes · General Counsel

$1.2M−41.0%May 13

Filings come from SEC EDGAR within a minute of the SEC accepting them. Without Pro, each one unlocks 4 hours later. Not investment advice.

Questions

Where does the data come from?

Corporate insider trades come straight from SEC Form 4 filings, pulled from EDGAR within a minute of each filing. Congress trades come from STOCK Act disclosures. All of it is public and free to browse here, and Pro sees the newest filings first.

How often is it updated?

Every minute from 6 AM to 10 PM New York time on weekdays, the hours the SEC accepts filings. Pro sees each filing as it lands. Without Pro, a filing unlocks 4 hours after the SEC accepts it.

Is following insider trades legal?

Yes. Insiders are legally required to disclose their trades within a few days. Acting on those public disclosures is completely legal. Trading on private, non-public information is illegal, but that's a different thing.

What does the iPhone app add?

We're building an iPhone app that alerts you to new filings and, if you choose, copies a buy into your own brokerage after you approve it. It isn't out yet, and the waitlist is free.